Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma

Endocrinology

Volumn 150, Issue 3, 2009, Pages 1112-1121

  Belcher, Scott M ^a   Ma, Xiaolan ^a   Le, Hoa H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(4 PROPYL[1H]PYRAZOLE 1,3,5 TRIYL)TRISPHENOL; 2,3 BIS(4 HYDROXYPHENYL)PROPIONITRILE DIARYLPROPIONITRILE; ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL MIGRATION; CELL VIABILITY; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN ACTIVITY; FEMALE; GRANULE CELL; GROWTH REGULATION; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEDULLOBLASTOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CEREBELLUM TUMOR; DOWN REGULATION; DRUG EFFECTS; DRUG SCREENING; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SPRAGUE DAWLEY RAT;

ADOLESCENT; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MICE; MICE, NUDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67649644713     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1363     Document Type: Article

References (50)

1. Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR 1999 Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. National Institutes of Health (NIH) Publication No. 99-4649. Bethesda, MD: NIH, Department of Health and Human Services
2. Rubin JB, Rowitch DH 2002 Medulloblastoma: a problem of developmental biology. Cancer Cell 2:7-8
3. Wechsler-Reya R, Scott MP 2001 The developmental biology of brain tumors. Annu Rev Neurosci 24:385-428
4. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F 2002 Childhood cancer survival in Europe and the United States. Cancer 95:1767-1772
5. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall, M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robison LL 2003 Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97:663-673
6. Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, Mertens AC, Packer RJ, Robison LL, Sklar CA 2003 Final Height and Body Mass Index among Adult Survivors of Childhood Brain Cancer: Childhood Cancer Survivor Study. J Clin Endocrinol Metab 88:4731-4739
7. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE 2004 Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399-408
8. Packer RJ 1999 Childhood medulloblastoma: progress and future challenges. Brain Dev 21:75-81
9. Lee SJ, McEwen BS 2001 Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-591
10. Takeyama J, Suzuki T, Inoue S, Kaneko C, Nagura H, Harada N, Sasano H 2001 Expression and cellular localization of estrogen receptors α and β in the human fetus. J Clin Endocrinol Metab 86:2258-2262
11. Fried G, Andersson E, Csöregh L, Enmark E, Gustafsson JA, Aanesen A, Osterlund C 2004 Estrogen receptor β is expressed in human embryonic brain cells and is regulated by 17β-estradiol. Eur J Neurosci 20:2345-2354
12. Belcher SM 1999 Regulated expression of estrogen receptor α and β mRNA in granule cells during development of the rat cerebellum. Brain Res Dev Brain Res 115:57-69
13. Jakab RL, Wong JK, Belcher SM 2001 Estrogen receptor-β immunoreactivity in differentiating cells of the developing rat cerebellum. J Comp Neurol 430:396-409
14. Zsarnovszky A, Belcher SM 2001 Identification of a developmental gradient of estrogen receptor expression and cellular localization in the developing and adult female rat primary somatosensory cortex. Brain Res Dev Brain Res 129:39-46
15. Zsarnovszky A, Smith T, Hajos F, Belcher SM 2002 Estrogen regulates GFAP-expression in specific subnuclei of the female rat interpeduncular nucleus: a potential role for estrogen receptor β. Brain Res 958:488-496
16. McEwen B 2002 Estrogen actions throughout the brain. Recent Prog Horm Res 57:357-384
17. Belcher SM, Zsarnovszky A 2001 Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J Pharmacol Exp Ther 299:408-414
18. Falkenstein E, Tillmann HC, Lost D, Feuring M, Lost D 2000 Multipleactions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 52:513-556
19. Wong JK, Le HH, Zsarnovszky A, Belcher SM 2003 Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J Neurosci 23:4984-4995
20. Zsarnovszky A, Le HH, Wang HS, Belcher SM 2005 Ontogeny of rapid estrogen-mediated ERK1/2 signaling in the rat cerebellar cortex in vivo: potent non-genomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 146:5388-5396
21. Sasahara K, Shikimi H, Haraguchi S, Sakamoto H, Honda S, Harada N, Tsutsui K 2007 Mode of action and functional significance of estrogen-inducing dendritic growth, spinogenesis, and synaptogenesis in the developing Purkinje cell. J Neurosci 27:7408-7417
22. Flototto T, Djahansouzi S, Glaser M, Hanstein B, Niederacher D, Brumm C, Beckmann MW 2001 Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33:451-457
23. Jordan VC, Brodie AM 2007 Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 72:7-25
24. Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC 2002 Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 94:552-560
25. Wong JK, Kennedy PR, Belcher SM 2001 Simplified serum- and steroid-free culture conditions for the high-throughput viability analysis of primary cultures of cerebellar neurons. J Neurosci Methods 110:45-55
26. Kirby M, Zsarnovszky A, Belcher SM 2004 Estrogen receptor expression in a human primitive neuroectodermal tumor cell line from the cerebral cortex: estrogen stimulates rapid ERK1/2 activation and receptor-dependent cell migration. Biochem Biophys Res Commun 319:753-758
27. Tanaka Y, Hongo K, Tada T, Kobayashi S 2003 What is the best method for reporting tumor diameter in vestibular schwannoma? Neurosurgery 53:634-638
28. Yue W, Zhou D, Chen S, Brodie A 1994 A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res 54:5092-5095
29. Yue W, Wang J, Savinov A, Brodie A 1995 Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model. Cancer Res 55:3073-3077
30. McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG 1998 Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. Clin Cancer Res 4:697-711
31. Jelovac D, Macedo L, Goloubeva OG, Handratta V, Brodie AMH 2005 Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model. Cancer Res 65:5439-5444
32. Choi I, Ko C, Park-Sarge OK, Nie R, Hess RA, Graves C, Katzenellenbogen BS 2001 Human estrogen receptor β-specific monoclonal antibodies: characterization and use in studies of estrogen receptor β protein expression in reproductive tissues. Mol Cell Endocrinol 181:139-150
33. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M 1998 Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 26:3505-3512
34. Bhat RA, Harnish DC, Stevis PE, Lyttle CR, Komm BS 1998 A novel human estrogen receptor β: identification and functional analysis of additional N-terminal amino acids. J Steroid Biochem Mol Biol 67:233-240
35. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM, Willson TM 1998 Cloning and characterization of human estrogen receptor β isoforms. Biochem Biophys Res Commun 47:75-78
36. Just I, Fritz G, Aktories K, Giry M, Popoff MR, Boquet P, Hegenbarth S, Eichel-Streiber C 1994 Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem 269:10706-10712
37. MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer RJ, Cogen P, Stephan DA 2001 Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29:143-152
38. Vasudevan N, Kow LM, Pfaff D 2005 Integration of steroid hormone initiated membrane action to genomic function in the brain. Steroids 70:388-396
39. Skliris GP, Carder PJ, Lansdown MR, Speirs V 2001 Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling? Br J Cancer 84:1095-1098
40. Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SAW 2004 Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10:7490-7499
41. Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Eden P, Peterson C, Malmstrom P, Isola J, Borg A, Ferno M 2007 Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma. Clin Cancer Res 13:1987-1994
42. Saji S, Omoto Y, Shimizu C 2002 Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62:4849-4853
43. Ma ZQ, Spreafico E, Pollio G, Santagati S, Conti E, Cattaneo E, Maggi, A 1993 Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc Natl Acad Sci USA 90:3740-3744
44. Leslie KK, Keefe D, Powell S, Naftolin F 1994 Estrogen receptors are identified in the glioblastoma cell line U138MG. J Soc Gynecol Investig 1:238-244
45. Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG, Agnantis NJ 2004 Estrogen receptor β (ERβ) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol 130:405-410
46. Broniscer A, Leite CdC, Lanchote VL, Machado TMS, Cristofani LM 2000 Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. J Clin Oncol 18:1246-1253
47. Robins HI, Won M, Seiferheld WF, Schultz CJ, Choucair AK, Brachman DG, Demas WF, Mehta MP 2006 Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. Neuro Oncol 8:47-52
48. Spence AM, Peterson RA, Scharnhorst JD, Silbergeld DL, Rostomily RC 2004 Phase II study of concurrent continuous temozolomide (TMZ) and tamoxifen (TMX) for recurrent malignant astrocytic gliomas. J Neurooncol 70:91-95
49. Puchner MJ, Giese A, Lohmann F, Cristante L 2004 High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients. Anticancer Res 24:4195-4203
50. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Hauser R, Heindel JJ, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, Keri RA, Knudsen KE, Laufer H, LeBlanc GA, Marcus M, McLachlan JA, Myers JP, Nadal A, Newbold RR, Olea N, Prins GS, Richter CA, Rubin BS, Sonnenschein C, Soto AM, Talsness CE, Vandenbergh JG, Vandenberg LN, Walser-Kuntz DR, Watson CS, Welshons WV, Wetherill Y, Zoeller RT 2007 Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24:131-138